Learn more

RIBOVAX BIOTECHNOLOGIES SA

Overview
  • Total Patents
    54
About

RIBOVAX BIOTECHNOLOGIES SA has a total of 54 patent applications. Its first patent ever was published in 2006. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Brazil. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are THERACLONE SCIENCES INC, ONCOIMMUNE INC and ASCLEPIUMM TAIWAN CO LTD.

Patent filings per year

Chart showing RIBOVAX BIOTECHNOLOGIES SAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Funaro Ada 25
#2 Landolfo Santo 15
#3 Gribaudo Giorgio 15
#4 Burioni Roberto 12
#5 Clementi Massimo 12
#6 Garotta Gianni 10
#7 Murphy Marianne 10
#8 Tomaino Barbara 8
#9 Novelli Francesco 8
#10 Cappello Paola 8

Latest patents

Publication Filing date Title
EP2248825A1 Antigen binding fragments of an antibody for use in treating and diagnosing ocular diseases
ZA200902889B Novel antigens and antibodies associated to pancreatic ductal adenocarcinoma
WO2009024445A1 Antibodies against human cytomegalovirus (hcmv)
EP2173771A1 Antibodies against human cytomegalovirus (hcmv)
BRPI0807084A2 SPECIFIC ANTIBODIES FOR VARUS VARICELA ZOSTER
NZ578413A Antibodies against human cytomegalovirus (hcmv)
AU2007331463A1 Antibodies against human cytomegalovirus (hCMV)
CN101578295A Novel antigens and antibodies associated to pancreatic ductal adenocarcinoma
BRPI0619908A2 method for immortalizing a cell population, cell population, oligoclonal or monoclonal cell population, cell culture, cell culture supernatant, DNA library, use of a cell population, cell culture, DNA supernatant or library, kit to identify and produce a monoclonal antibody, method to produce a cell culture, and method to produce a monoclonal antibody
CN101258243A Novel phage display technologies